Multimed Inc

SHERPA: Unknown

People

  1. Bott
    Bott
  2. Choi
    Choi
  3. De Camilli
    De Camilli
  4. Erinjeri
    Erinjeri
  5. Fischer
    Fischer
  6. Marinelli
    Marinelli
  7. Moufarrij
    Moufarrij
  8. O'Cearbhaill
    O'Cearbhaill
  9. Rajendram
    Rajendram
  10. Yarmohammadi
    Yarmohammadi

Groups

  1. Anesthesiology Service (2)
  2. Anesthesiology and Critical Care Medicine (2)
  3. Center for Pancreatic Cancer Research (1)
  4. Critical Care Center Leadership (1)
  5. Critical Care Center (1)
  6. Critical Care Medicine (1)
  7. Department of Medicine (1)
  8. GDMT, Medicine (1)
  9. GME, Surgery (1)
  10. Graduate Medical Education (1)
Search Within
  1. "Review"
Formats
  1. Review (7)
Groups
  1. Anesthesiology Service (2)
  2. Anesthesiology and Critical Care Medicine (2)
  3. Center for Pancreatic Cancer Research (1)
  4. Critical Care Center (1)
  5. Critical Care Center Leadership (1)
  6. Critical Care Medicine (1)

More Groups

People
  1. Alessandro De Camilli (1)
  2. Anita Karimi (1)
  3. Brett Marinelli (1)
  4. Gregory Fischer (1)
  5. Hooman Yarmohammadi (1)
  6. Jehee Choi (1)

More People

Years
  1. 2023 (6)
  2. 2021 (1)
Publications
  1. Current Oncology (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel therapeutics in ovarian cancer: Expanding the toolbox
    Review

    Moufarrij, S.; O'Cearbhaill, R. E.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Novel cellular and immunotherapy: Toxicities and perioperative implications
    Review

    De Camilli, A.; Fischer, G.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Anti-glycolytic drugs in the treatment of hepatocellular carcinoma: Systemic and locoregional options
    Review

    Pourbaghi, M.; Haghani, L.; Zhao, K.; Karimi, A.; Marinelli, B.; Erinjeri, J. P.; Geschwind, J. F. H.; Yarmohammadi, H.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Management and prevention of cellular-therapy-related toxicity: Early and late complications
    Review

    Mucha, S. R.; Rajendram, P.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Tumors of the digestive system: Comprehensive review of ancillary testing and biomarkers in the era of precision medicine
    Review

    Molnar, A.; Monroe, H.; Basri Aydin, H.; Arslan, M. E.; Lightle, A.; Lee, H.; El Jabbour, T.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Different re-irradiation techniques after breast-conserving surgery for recurrent or new primary breast cancer
    Review

    Abeloos, C. H.; Purswani, J. M.; Galavis, P.; McCarthy, A.; Hitchen, C.; Choi, J. I.; Gerber, N. K.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Meta-analysis of neoadjuvant immunotherapy for patients with resectable non-small cell lung cancer
    Review

    Cao, C.; Le, A.; Bott, M.; Yang, C. F. J.; Gossot, D.; Melfi, F.; Tian, D. H.; Guo, A.
    Current Oncology (2021)

    Fulltext@MSK | Save

    • Multimed Inc – authorized name for: